Sanofi (SNY) Change in Accured Expenses (2020 - 2021)
Sanofi (SNY) posted Change in Accured Expenses of -$2.5 million for Q4 2021, up 53.09% sequentially from -$5.4 million in Q4 2020, and up 53.09% YoY from -$1.6 million in Q4 2020.
Sanofi (SNY) Change in Accured Expenses (2020 - 2021) Analysis & Trends
Sanofi has reported Change in Accured Expenses for 2 years, with the latest figure at -$2.5 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 2.32 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 1.20 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | - |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 852.00 Mn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 338.00 Mn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -2.52 Mn |
| Dec 31, 2021 | -2.52 Mn |
| Dec 31, 2020 | -5.37 Mn |
| Dec 31, 2020 | -5.37 Mn |